Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sinistrin is a naturally occurring polyfructosan, a polymer of fructose, used as a diagnostic agent to measure glomerular filtration rate (GFR). Chemically similar to inulin but with improved water solubility, it serves as an ideal exogenous marker because it is freely filtered by the renal glomeruli and undergoes no tubular secretion, reabsorption, or metabolism. It is typically administered as an intravenous bolus to provide an accurate measurement of GFR (mGFR), particularly in clinical scenarios where creatinine-based estimation equations (eGFR) are known to be inaccurate, such as in patients with near-normal kidney function or in potential live kidney donors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sinistrin.